1. Home
  2. ABBV
  3. ABBV News

Latest AbbVie Inc. (ABBV) News on May 19, 2025

Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New Deals
ABBV

Zacks

3 days ago

Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New Deals

1 Healthcare Stock to Keep an Eye On and 2 to Ignore
ABBV

StockStory

3 days ago

1 Healthcare Stock to Keep an Eye On and 2 to Ignore

FDA awards cancer drug approvals to AbbVie and MSD
ABBV

Pharmaceutical Technology

3 days ago

FDA awards cancer drug approvals to AbbVie and MSD

AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer
ABBV

Zacks

4 days ago

AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer

AbbVie stakes $335M on a startup’s RNAi drugs
ABBV

BioPharma Dive

4 days ago

AbbVie stakes $335M on a startup’s RNAi drugs

AbbVie expands siRNA push with $335m ADARx deal
ABBV

Pharmaceutical Technology

4 days ago

AbbVie expands siRNA push with $335m ADARx deal

FDA approves Roche’s MET protein expression detecting assay for NSQ-NSCLC
ABBV

Medical Device Network

4 days ago

FDA approves Roche’s MET protein expression detecting assay for NSQ-NSCLC

Regeneron Upgraded as AbbVie Catches Policy Heat
ABBV

GuruFocus.com

4 days ago

Regeneron Upgraded as AbbVie Catches Policy Heat

FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases
ABBV

Benzinga

4 days ago

FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases

ABBV

MT Newswires

5 days ago

AbbVie Says US FDA Approved Emrelis for Lung Cancer Indication

US FDA approves AbbVie's drug for a type of lung cancer
ABBV

Reuters

5 days ago

US FDA approves AbbVie's drug for a type of lung cancer

U.S. FDA Approves EMRELIS™ (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression
ABBV

PR Newswire

5 days ago

U.S. FDA Approves EMRELIS™ (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression

AbbVie Inc. (ABBV): Among the Best Dividend Growth Stocks with High Yields
ABBV

Insider Monkey

5 days ago

AbbVie Inc. (ABBV): Among the Best Dividend Growth Stocks with High Yields

ABBV

Investing.com

5 days ago

AbbVie, Merck cut to Neutral at Citi

ABBV

MT Newswires

5 days ago

AbbVie, ADARx Pharmaceuticals Launch Collaboration Focused on siRNA Therapies for Multiple Diseases

AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas
ABBV

PR Newswire

5 days ago

AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas

ABBV

MT Newswires

5 days ago

Citigroup Downgrades AbbVie to Neutral From Buy, Adjusts Price Target to $205 From $210

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses
ABBV

StockStory

5 days ago

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

Is AbbVie Inc. (ABBV) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?
ABBV

Insider Monkey

5 days ago

Is AbbVie Inc. (ABBV) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?

ABBV

Thomson Reuters StreetEvents

6 days ago

Q1 2025 Regenxbio Inc Earnings Call

Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared
ABBV

Zacks

6 days ago

Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared

Trump's drug price order is part request, part threat: Analyst
ABBV

Yahoo Finance Video

6 days ago

Trump's drug price order is part request, part threat: Analyst

S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'
ABBV

Investor's Business Daily

6 days ago

S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'

How Trump could go about executing order to slash drug prices
ABBV

Yahoo Finance Video

6 days ago

How Trump could go about executing order to slash drug prices

Trump expected to sign order to slash US drug prices
ABBV

Yahoo Finance Video

7 days ago

Trump expected to sign order to slash US drug prices

US-China trade truce, April CPI, drug prices: 3 Things
ABBV

Yahoo Finance Video

7 days ago

US-China trade truce, April CPI, drug prices: 3 Things

Recession Worries? Here's 1 of the Best Dividend Stocks for Turbulent Times
ABBV

Motley Fool

8 days ago

Recession Worries? Here's 1 of the Best Dividend Stocks for Turbulent Times

2 High-Yield Dividend Stocks to Buy in May and Hold Forever
ABBV

Motley Fool

9 days ago

2 High-Yield Dividend Stocks to Buy in May and Hold Forever

AbbVie Inc. (ABBV): Among the Best Income Stocks to Invest in Now
ABBV

Insider Monkey

9 days ago

AbbVie Inc. (ABBV): Among the Best Income Stocks to Invest in Now

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks
ABBV

StockStory

10 days ago

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

ABBV

MT Newswires

11 days ago

BNP Paribas Exane Adjusts Price Target on AbbVie to $195 From $193, Maintains Neutral Rating

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates
ABBV

Zacks

11 days ago

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates

Q1 Earnings Recap: AbbVie (NYSE:ABBV) Tops Therapeutics Stocks
ABBV

StockStory

11 days ago

Q1 Earnings Recap: AbbVie (NYSE:ABBV) Tops Therapeutics Stocks

AbbVie Inc. (ABBV): A Bull Case Theory
ABBV

Insider Monkey

11 days ago

AbbVie Inc. (ABBV): A Bull Case Theory

The Zacks Analyst Blog Highlights Johnson & Johnson and AbbVie
ABBV

Zacks

12 days ago

The Zacks Analyst Blog Highlights Johnson & Johnson and AbbVie

Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better.
ABBV

The Wall Street Journal

12 days ago

Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better.

If You Invested $10K In AbbVie Stock 10 Years Ago, How Much Would You Have Now?
ABBV

Benzinga

12 days ago

If You Invested $10K In AbbVie Stock 10 Years Ago, How Much Would You Have Now?

JNJ vs. ABBV: Which Pharma Powerhouse Has Better Growth Prospects?
ABBV

Zacks

13 days ago

JNJ vs. ABBV: Which Pharma Powerhouse Has Better Growth Prospects?

AbbVie to Present at the Bank of America Securities Healthcare Conference
ABBV

PR Newswire

13 days ago

AbbVie to Present at the Bank of America Securities Healthcare Conference

ChatGPT Stock Advice: AbbVie Inc. (ABBV) Among Top Stock Recommendations
ABBV

Insider Monkey

13 days ago

ChatGPT Stock Advice: AbbVie Inc. (ABBV) Among Top Stock Recommendations

On tariffs and pricing, Big Pharma CEOs are waiting out the storm while planning for the worst
ABBV

Pharma Voice

13 days ago

On tariffs and pricing, Big Pharma CEOs are waiting out the storm while planning for the worst

1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar
ABBV

StockStory

13 days ago

1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
ABBV

Motley Fool

15 days ago

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?

AbbVie Stock: Using A Long-Term Leap Ratio Spread On This Pharma Giant
ABBV

Investor's Business Daily

17 days ago

AbbVie Stock: Using A Long-Term Leap Ratio Spread On This Pharma Giant

Transforming HR Leadership: Inside The Darla Moore School’s Standout MHR Program
ABBV

Poets & Quants

17 days ago

Transforming HR Leadership: Inside The Darla Moore School’s Standout MHR Program

BOTOX® Cosmetic (onabotulinumtoxinA) Continues its Mission of Empowering Entrepreneurs Through "The Confidence Project"
ABBV

PR Newswire

17 days ago

BOTOX® Cosmetic (onabotulinumtoxinA) Continues its Mission of Empowering Entrepreneurs Through "The Confidence Project"

ABBV

Argus Research

18 days ago

Analyst Report: AbbVie Inc

ABBV

Argus Research

18 days ago

Market Digest: BKNG, AMT, SBUX, MSCI, DLR, ABBV, QRVO, SNAP

ABBV

Argus Research

18 days ago

Market Digest: BKNG, AMT, SBUX, MSCI, DLR, ABBV, QRVO, SNAP

High Growth Tech Stocks In The US Market April 2025
ABBV

Simply Wall St.

19 days ago

High Growth Tech Stocks In The US Market April 2025

FDA approves AbbVie’s upadacitinib for giant cell arteritis
ABBV

Pharmaceutical Technology

19 days ago

FDA approves AbbVie’s upadacitinib for giant cell arteritis

Moderna (MRNA) Reports Earnings Tomorrow: What To Expect
ABBV

StockStory

19 days ago

Moderna (MRNA) Reports Earnings Tomorrow: What To Expect

Amgen (AMGN) Reports Earnings Tomorrow: What To Expect
ABBV

StockStory

19 days ago

Amgen (AMGN) Reports Earnings Tomorrow: What To Expect

Biogen Earnings: What To Look For From BIIB
ABBV

StockStory

19 days ago

Biogen Earnings: What To Look For From BIIB

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q1 Earnings
ABBV

StockStory

19 days ago

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q1 Earnings

AbbVie (NYSE:ABBV) Receives FDA Approval For RINVOQ In Treating Giant Cell Arteritis
ABBV

Simply Wall St.

20 days ago

AbbVie (NYSE:ABBV) Receives FDA Approval For RINVOQ In Treating Giant Cell Arteritis

ABBV

MT Newswires

20 days ago

AbbVie Says Rinvoq Medication Gets FDA Approval to Treat Giant Cell Arteritis

ABBV

MT Newswires

20 days ago

Guggenheim Adjusts AbbVie Price Target to $216 From $214, Maintains Buy Rating

RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)
ABBV

PR Newswire

20 days ago

RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)

ABBV

Argus Research

20 days ago

Technical Assessment: Neutral in the Intermediate-Term

United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect
ABBV

StockStory

20 days ago

United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect

Why AbbVie Stock Trounced the Market Today
ABBV

Motley Fool

20 days ago

Why AbbVie Stock Trounced the Market Today

S&P 500 Gains and Losses Today: AbbVie Stock Advances After Beat-and-Raise Earnings Report
ABBV

Investopedia

20 days ago

S&P 500 Gains and Losses Today: AbbVie Stock Advances After Beat-and-Raise Earnings Report

AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts
ABBV

Barrons.com

21 days ago

AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts

ALX Oncology’s CD47-blocker and Keytruda combo fails in two Phase II trials
ABBV

Clinical Trials Arena

21 days ago

ALX Oncology’s CD47-blocker and Keytruda combo fails in two Phase II trials

3 Dividend Stocks to Buy and Hold for the Next Decade
ABBV

Motley Fool

21 days ago

3 Dividend Stocks to Buy and Hold for the Next Decade

ABBV

MT Newswires

21 days ago

HSBC Adjusts Price Target on AbbVie to $205 From $230, Maintains Buy Rating

ABBV

MT Newswires

21 days ago

Raymond James Adjusts Price Target on AbbVie to $227 From $220, Maintains Outperform Rating

Company News for Apr 28, 2025
ABBV

Zacks

21 days ago

Company News for Apr 28, 2025

Should Investors Be Worried About Dividend King AbbVie?
ABBV

Motley Fool

21 days ago

Should Investors Be Worried About Dividend King AbbVie?

AbbVie Inc. (ABBV): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential
ABBV

Insider Monkey

21 days ago

AbbVie Inc. (ABBV): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential

AbbVie First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
ABBV

Simply Wall St.

22 days ago

AbbVie First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
ABBV

Motley Fool

22 days ago

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz
ABBV

TipRanks

23 days ago

China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz

AbbVie Inc (ABBV) Q1 2025 Earnings Call Highlights: Strong Growth in Immunology and ...
ABBV

GuruFocus.com

23 days ago

AbbVie Inc (ABBV) Q1 2025 Earnings Call Highlights: Strong Growth in Immunology and ...

ABBV

Thomson Reuters StreetEvents

23 days ago

Q1 2025 AbbVie Inc Earnings Call

How Much Would It Take To Earn $100 A Month From AbbVie Stock
ABBV

Benzinga

23 days ago

How Much Would It Take To Earn $100 A Month From AbbVie Stock

ABBV

Morningstar Research

23 days ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

Why AbbVie Stock Topped the Market Today
ABBV

Motley Fool

23 days ago

Why AbbVie Stock Topped the Market Today

Is AbbVie Inc. (ABBV) the Best Dividend Stock to Buy for Long-Term Passive Income?
ABBV

Insider Monkey

23 days ago

Is AbbVie Inc. (ABBV) the Best Dividend Stock to Buy for Long-Term Passive Income?

AbbVie Hikes Its Outlook On The Back Of Two Powerhouse Drugs
ABBV

Investor's Business Daily

23 days ago

AbbVie Hikes Its Outlook On The Back Of Two Powerhouse Drugs

ABBV

MT Newswires

23 days ago

Sector Update: Health Care Stocks Advance Late Afternoon

ABBV

MT Newswires

24 days ago

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

ABBV

MT Newswires

24 days ago

Sector Update: Health Care

AbbVie Jumps After Hiking Its Outlook On The Back Of Strong Immunology Sales
ABBV

Investor's Business Daily

24 days ago

AbbVie Jumps After Hiking Its Outlook On The Back Of Strong Immunology Sales

AbbVie Stock Jumps as Earnings Beat, Guidance Raised. But Tariffs Could Bite Yet.
ABBV

Barrons.com

24 days ago

AbbVie Stock Jumps as Earnings Beat, Guidance Raised. But Tariffs Could Bite Yet.

AbbVie Inc. (ABBV): One of the Growing Dividend Stocks with Low PE Ratios
ABBV

Insider Monkey

24 days ago

AbbVie Inc. (ABBV): One of the Growing Dividend Stocks with Low PE Ratios

AbbVie (NYSE:ABBV) Reports Bullish Q1
ABBV

StockStory

24 days ago

AbbVie (NYSE:ABBV) Reports Bullish Q1

ABBV

MT Newswires

24 days ago

AbbVie Q1 Adjusted Earnings, Revenue Increase; 2025 Adjusted EPS Outlook Lifted

ABBV

Associated Press Finance

24 days ago

AbbVie: Q1 Earnings Snapshot

AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines
ABBV

PR Newswire

25 days ago

AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines

Merck (MRK) Q1 Earnings and Revenues Top Estimates
ABBV

Zacks

25 days ago

Merck (MRK) Q1 Earnings and Revenues Top Estimates

Buy Stock in These Healthcare Leaders as Q1 Earnings Approach? ABBV, HCA
ABBV

Zacks

25 days ago

Buy Stock in These Healthcare Leaders as Q1 Earnings Approach? ABBV, HCA

Why AbbVie Inc. (ABBV) is Among the Best Stocks That Will Always Grow
ABBV

Insider Monkey

a month ago

Why AbbVie Inc. (ABBV) is Among the Best Stocks That Will Always Grow

The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi
ABBV

Zacks

a month ago

The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi

Buy, Sell or Hold ABBV Stock? Key Tips Ahead of Q1 Earnings
ABBV

Zacks

a month ago

Buy, Sell or Hold ABBV Stock? Key Tips Ahead of Q1 Earnings

2 High-Yield Dividend Stocks to Buy for Passive Income
ABBV

Motley Fool

a month ago

2 High-Yield Dividend Stocks to Buy for Passive Income

Eli Lilly, Vertex, AbbVie, and More Pharma Stocks to Own as Tariffs Loom
ABBV

Barrons.com

a month ago

Eli Lilly, Vertex, AbbVie, and More Pharma Stocks to Own as Tariffs Loom

Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
ABBV

Zacks

a month ago

Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for

ABBV

Investing.com

a month ago

Cantor initiates coverage of U.S. large-cap pharma stocks: Gilead, AbbVie at Buy

Share on Social Networks: